A joint report from the WHO and European health officials finds 79% of new TB cases are going undetected, which results in delayed treatment and more transmission of the disease.
Federal law states that acting directors at the CDC have 210 days to serve, after which the administration should name a nominee for the position.
The factors may continue to influence TB trends over time, the authors say.
A new modeling study suggests that disruptions in international donor funding could outweigh the benefits of a novel TB vaccine.
A phase 4 trial in Brazil finds 1-month and 3-month treatment regimens are safe and effective options for preventing active tuberculosis.
A model that tracks the impact of USAID funding cuts estimates that more than 760,000 people have died as a result of those cuts since January 2025.
Roughly half of TB meningitis patients die or incur severe, permanent damage.
The results show sorfequiline, when used in combination with 2 other drugs, had greater activity against drug-susceptible TB at 8 weeks than existing treatments.
The global TB incidence rate fell by 2% in 2024, and TB deaths fell by 3%, but WHO officials say the progress could be wiped out by funding cuts.
In a new report, the WHO says financing and access strategies need to be implemented to ensure the demand for future TB vaccines doesn't outstrip supply.
